EAM
KNTE

Exome Asset Management’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Exome Asset Management’s Portfolio KNTE Stock Details KNTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-83,848
Closed -$199K – 76
2023
Q4 		$199K Buy
+83,848
New +$199K 0.2% 52